Stocks
Lakewood-Amedex Biotherapeutics, Inc.LABT
NASDAQHealthcareBiotechnology$0.31
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel antimicrobial and anti-inflammatory therapies, with a lead candidate targeting serious infections. Its pipeline focuses on addressing unmet medical needs in hospital and specialty care settings. Investors track LABT for its potential in the infectious disease space, though the company has limited revenue and relies on funding for clinical trials.
52W Range: $0.28-$98.20
Congressional Interest in Lakewood-Amedex Biotherapeutics, Inc. (LABT)
No congressional trades have been disclosed for Lakewood-Amedex Biotherapeutics, Inc. (LABT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LABT?
No congressional trades found for this stock.